RecruitingWomenAgingMenopause
Beta3-adrenergic Receptors and Cardiovascular Function in Aging Women
Eligible age
18–70 yrs
Accepts
Women
Locations
1 state
Healthy volunteers
Yes
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
To determine if vascular beta3 adrenergic receptors are present and functional in aging women and can be targeted to attenuate sympathetic vasoconstriction and enhance vascular function in aging women.
Sponsor: University of Missouri-Columbia
You may qualify if…
- ✓ Healthy women,
- ✓ Assigned female at birth,
- ✓ 18-70 years of age,
- ✓ Body mass index \<18 or ≥30 kg/m2,
You may not qualify if…
- ✕ Assigned male at birth,
- ✕ Pregnancy,
- ✕ Breastfeeding,
- ✕ History of hormone replacement therapy, chemical menopause, or oophor-ectomy
- ✕ Polycystic ovarian syndrome or Primary ovarian insufficiency,
- ✕ Current smoking/Nicotine use,
- ✕ Blood pressure ≥140/90 mmHg,
- ✕ Increased risk of bleeding, pro-coagulant disorders, clotting disorders, anticoagulation therapy,
Where it's recruiting
Missouri
Columbia
Source: ClinicalTrials.gov · NCT07674680 · last updated 2026-09-10